Safety and Efficacy of Thrombolytic Therapy Using rt-PA (Alteplase) in Acute Ischemic Stroke

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left"> Time to reach</td><td align="center">% of patients</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">0–3 hr</td><td align="center">39.13%</td></tr><tr><td align="left">&gt;3-4 hr</td><td align="center">21.73%</td></tr><tr><td align="left">&gt;4-5 hr</td><td align="center">13.04%</td></tr><tr><td align="left">&gt;5 hr</td><td align="center">0%</td></tr><tr><td align="left"> Not aware</td><td align="center">26.08%</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Time to reach hospital in the study population.

International Scholarly Research Notices

tab3

Table 3

Table 3: Safety and Efficacy of Thrombolytic Therapy Using rt-PA (Alteplase) in Acute Ischemic Stroke 